These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31657834)

  • 21. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.
    Arnold SE; Hyman BT; Flory J; Damasio AR; Van Hoesen GW
    Cereb Cortex; 1991; 1(1):103-16. PubMed ID: 1822725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease.
    Liu AK; Chang RC; Pearce RK; Gentleman SM
    Acta Neuropathol; 2015 Apr; 129(4):527-40. PubMed ID: 25633602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analysis of neurofibrillary pathology in a general population to reappraise neuropathological criteria for senile dementia of the neurofibrillary tangle type (tangle-only dementia): the Hisayama Study.
    Noda K; Sasaki K; Fujimi K; Wakisaka Y; Tanizaki Y; Wakugawa Y; Kiyohara Y; Iida M; Aizawa H; Iwaki T
    Neuropathology; 2006 Dec; 26(6):508-18. PubMed ID: 17203586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are Linear Measurements of the Nucleus Basalis of Meynert Suitable as a Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer Disease?
    Jethwa KD; Dhillon P; Meng D; Auer DP;
    AJNR Am J Neuroradiol; 2019 Dec; 40(12):2039-2044. PubMed ID: 31727757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal loss of the nucleus basalis of Meynert in primary progressive aphasia is associated with Alzheimer's disease neuropathological changes.
    Schaeverbeke J; Tomé SO; Ronisz A; Ospitalieri S; von Arnim CAF; Otto M; Vandenberghe R; Thal DR
    Alzheimers Dement; 2023 Apr; 19(4):1440-1451. PubMed ID: 36170544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lateral thinking: Neurodegeneration of the cortical cholinergic system in Alzheimer's disease.
    Crockett RA; Casselton C; Howard TM; Wilkins KB; Seo G; Brontë-Stewart HM;
    Neurobiol Dis; 2024 Oct; 201():106677. PubMed ID: 39307400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
    Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
    Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: a quantitative study in humans.
    Theofilas P; Ehrenberg AJ; Nguy A; Thackrey JM; Dunlop S; Mejia MB; Alho AT; Paraizo Leite RE; Rodriguez RD; Suemoto CK; Nascimento CF; Chin M; Medina-Cleghorn D; Cuervo AM; Arkin M; Seeley WW; Miller BL; Nitrini R; Pasqualucci CA; Filho WJ; Rueb U; Neuhaus J; Heinsen H; Grinberg LT
    Neurobiol Aging; 2018 Jan; 61():1-12. PubMed ID: 29031088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropathologic correlates of activities of daily living in Alzheimer disease.
    Marshall GA; Fairbanks LA; Tekin S; Vinters HV; Cummings JL
    Alzheimer Dis Assoc Disord; 2006; 20(1):56-9. PubMed ID: 16493237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
    Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
    Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two distinct subgroups of senile dementia of Alzheimer type: quantitative study of neurofibrillary tangles.
    Mizuno Y; Ikeda K; Tsuchiya K; Ishihara R; Shibayama H
    Neuropathology; 2003 Dec; 23(4):282-9. PubMed ID: 14719543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer's disease.
    Ohm DT; Fought AJ; Martersteck A; Coventry C; Sridhar J; Gefen T; Weintraub S; Bigio E; Mesulam MM; Rogalski E; Geula C
    Brain Pathol; 2021 Jan; 31(1):189-204. PubMed ID: 33010092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert.
    Sassin I; Schultz C; Thal DR; Rüb U; Arai K; Braak E; Braak H
    Acta Neuropathol; 2000 Sep; 100(3):259-69. PubMed ID: 10965795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer's disease progression.
    Shafiee N; Fonov V; Dadar M; Spreng RN; Collins DL
    Neurobiol Aging; 2024 Jul; 139():54-63. PubMed ID: 38608458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer disease without neocortical neurofibrillary tangles: "a second look".
    Tiraboschi P; Sabbagh MN; Hansen LA; Salmon DP; Merdes A; Gamst A; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Apr; 62(7):1141-7. PubMed ID: 15079014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups.
    Gearing M; Lynn M; Mirra SS
    Arch Neurol; 1999 Feb; 56(2):203-8. PubMed ID: 10025425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
    Mohanty R; Ferreira D; Frerich S; Muehlboeck JS; Grothe MJ; Westman E;
    Neurology; 2022 Jul; 99(4):e323-e333. PubMed ID: 35609990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.